This company has shut down. Provention Bio is no longer operating — its last tracked round was a Post-IPO Equity in 2023.
Explore the Startup GraveyardProvention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.
Provention Bio has raised $35.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2023.
Provention Bio's investors include Sanofi, Hercules Capital, Armistice Capital, MDB Capital Group, JDRF T1D Fund.
Provention Bio is headquartered in Red Bank, United States.
Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.
Provention Bio is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Provention Bio — Funding & Investors." VCBacked, February 13, 2023, https://www.vcbacked.co/company/provention-bio. Accessed August 15, 2026.
VCBacked. (2023). Provention Bio — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/provention-bio
{{cite web |title=Provention Bio — Funding & Investors |url=https://www.vcbacked.co/company/provention-bio |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated